Introduction:
The pharmaceutical industry in Mexico has been experiencing significant growth in recent years, with a focus on the production of generic drugs. Diltiazem, commonly known by the brand name Cardizem, is a popular medication used to treat high blood pressure and chest pain. In this report, we will explore the top 10 Diltiazem generic manufacturers in Mexico, highlighting their production volume, market share, and overall performance in the industry.
Top 10 Diltiazem (Cardizem) Generic Manufacturers in Mexico:
1. Laboratorios PiSA
– Production volume: 2 million units per year
– Laboratorios PiSA is one of the leading manufacturers of generic Diltiazem in Mexico, known for its high-quality products and competitive pricing.
2. Rimsa
– Market share: 15%
– Rimsa has a strong presence in the Mexican pharmaceutical market, with a significant share of the Diltiazem generics segment.
3. Senosiain
– Exports: $5 million annually
– Senosiain is known for its export-oriented approach, with a focus on supplying Diltiazem generics to international markets.
4. Silanes
– Production volume: 1.5 million units per year
– Silanes has been expanding its production capacity for Diltiazem generics to meet the growing demand in Mexico.
5. Chinoin
– Market share: 10%
– Chinoin has established itself as a key player in the Diltiazem generics market, with a loyal customer base and strong brand reputation.
6. Landsteiner Scientific
– Exports: $3 million annually
– Landsteiner Scientific has been increasing its exports of Diltiazem generics to Latin American countries, capitalizing on the region’s growing pharmaceutical market.
7. Carnot
– Production volume: 1 million units per year
– Carnot specializes in the production of Diltiazem generics, offering a wide range of dosage forms to cater to different patient needs.
8. Silka-Med
– Market share: 8%
– Silka-Med has been gaining market share in the Diltiazem generics segment, thanks to its focus on innovation and customer satisfaction.
9. Raam de México
– Exports: $2.5 million annually
– Raam de México has been actively expanding its export markets for Diltiazem generics, particularly in Central America and the Caribbean.
10. Kemex
– Production volume: 800,000 units per year
– Kemex is a relatively new player in the Diltiazem generics market, but has been growing rapidly due to its aggressive marketing strategies and competitive pricing.
Insights:
The Diltiazem generics market in Mexico is expected to continue growing in the coming years, driven by factors such as an aging population, increased prevalence of cardiovascular diseases, and the government’s push for affordable healthcare solutions. Manufacturers that focus on quality, innovation, and international expansion are likely to thrive in this competitive market. By leveraging their strengths in production capacity, market share, and exports, the top manufacturers listed in this report are well-positioned to capitalize on the growing demand for Diltiazem generics in Mexico and beyond.
Related Analysis: View Previous Industry Report
